O-1656

O-1656
臨床資料
ATC碼	未分配;
識別資訊
	IUPAC命名法 2-cycloheptyl-5-(2-methyloctan-2-yl)benzene-1,3-diol; ;
CAS號	468083-75-2
PubChem CID	58803980;
化學資訊
化學式	C22H36O2
摩爾質量	332.53 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES CCCCCCC(C)(C)C1=CC(=C(C(=C1)O)C2CCCCCC2)O;
	InChI InChI=1S/C22H36O2/c1-4-5-6-11-14-22(2,3)18-15-19(23)21(20(24)16-18)17-12-9-7-8-10-13-17/h15-17,23-24H,4-14H2,1-3H3; Key:AECZEBWFCJESSN-UHFFFAOYSA-N;

O-1656是一種人工合成的大麻素，化學式C
22H
36O
2，由Organix Inc的科學家在2002開發^[1]^[2]^[3]，其苯環連接一個環庚基而非合成大麻素常見的環己基。

參考文獻

^ WO application 03091189,Martin BR, Razdan RK,「Cannabinoids」,發表於6 November 2003,指定於University of Virginia
^ Wiley JL, Beletskaya ID, Ng EW, Dai Z, Crocker PJ, Mahadevan A, Razdan RK, Martin BR. Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists. The Journal of Pharmacology and Experimental Therapeutics. May 2002, 301 (2): 679–89. PMID 11961073. S2CID 12741224. doi:10.1124/jpet.301.2.679.
^ Adam J, Cowley PM, Kiyoi T, Morrison AJ, Mort CJ. Recent progress in cannabinoid research. Progress in Medicinal Chemistry. 2006, 44: 207–329. ISBN 9780444517371. PMID 16697899. doi:10.1016/S0079-6468(05)44406-9.